Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona, Spain

The presentations underline the substantial real-world evidence available for Oncotype DX and reflect the growing adoption of the test across Europe to personalize and improve the quality of clinical decisions, leading to better patient outcomes and more cost-effective treatment.

Access to the full press release

Find an actor

CES 2019 Las Vegas - Swiss Pavilion08.01.2019

Join the Swiss Pavilion during the Consumer Electronic Show from 8 to 11 January 2019 in Las Vegas, USA.

"Using water molecules to unlock neurons' secrets"

EPFL News : "EPFL researchers have developed a method to observe the electrical activity of neurons by analyzing the...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn